NASDAQ:CNTX
Context Therapeutics Inc.
- Stock
Last Close
1.68
14/05 20:00
Market Cap
15.49M
Beta: -
Volume Today
99.33K
Avg: 99.97K
PE Ratio
−0.80
PFCF: −0.90
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
net income | -6.38M - | 6.64M 204.08% | -10.46M 257.38% | -14.84M 41.88% | -23.96M 61.53% | |
depreciation and amortization | 9.27K - | 12.04K 29.95% | ||||
deferred income tax | ||||||
stock based compensation | 775.25K - | 219.25K 71.72% | 511.08K 133.11% | 976.44K 91.05% | 1.08M 10.28% | |
change in working capital | 561.79K - | 1.32M 134.66% | -2.22M 268.77% | -277.52K 87.53% | 1.45M 621.28% | |
accounts receivables | ||||||
inventory | ||||||
accounts payables | 505.41K - | 556.27K 10.06% | -866.01K 255.68% | -787.89K 9.02% | 1.45M 283.61% | |
other working capital | 56.38K - | 762.03K 1,251.58% | -1.36M 278.32% | 510.37K 137.56% | -1.45M 383.46% | |
other non cash items | 2.21M - | -9.22M 516.85% | 3.37M 136.58% | 578.52K 82.84% | 22.88M 3,854.10% | |
net cash provided by operating activities | -2.84M - | -1.03M 63.52% | -8.80M 750.50% | -13.55M 53.98% | -22.88M 68.83% | |
investments in property plant and equipment | -250K - | -536.84K 114.73% | ||||
acquisitions net | ||||||
purchases of investments | ||||||
sales maturities of investments | ||||||
other investing activites | ||||||
net cash used for investing activites | -250K - | -536.84K 114.73% | ||||
debt repayment | -1.96M - | -149.05K 92.39% | ||||
common stock issued | 1M - | 53.41M 5,241.12% | 309.39K 99.42% | |||
common stock repurchased | ||||||
dividends paid | ||||||
other financing activites | 3.91M - | 298.11K 92.39% | 4.98M 1,571.49% | -411.46K 108.26% | ||
net cash used provided by financing activities | 1.96M - | 1.15M 41.30% | 58.39M 4,981.92% | -102.07K 100.17% | ||
effect of forex changes on cash | ||||||
net change in cash | -878.69K - | 114.43K 113.02% | 49.34M 43,020.53% | -14.19M 128.75% | -21.05M 48.35% | |
cash at beginning of period | 1.11M - | 226.60K 79.50% | 341.04K 50.50% | 49.69M 14,468.97% | 35.50M 28.56% | |
cash at end of period | 226.60K - | 341.04K 50.50% | 49.69M 14,468.97% | 35.50M 28.56% | 14.45M 59.29% | |
operating cash flow | -2.84M - | -1.03M 63.52% | -8.80M 750.50% | -13.55M 53.98% | -22.88M 68.83% | |
capital expenditure | -250K - | -536.84K 114.73% | ||||
free cash flow | -2.84M - | -1.03M 63.52% | -9.05M 774.67% | -14.09M 55.66% | -22.88M 62.40% |
All numbers in USD (except ratios and percentages)